Middle Georgia Comprehensive Cancer Center to Open in November
The groundbreaking ceremony for Macon’s new cancer treatment center was held on February 13 at the campus of Coliseum Medical Center in Macon, Georgia. Dr. Bruce Feinberg, CEO of Georgia Cancer Specialists, acted as the shovel-wielder at the ceremony. “Today marks the official start of a project that will improve cancer care in Macon and […]
GCS Physicians Attend 2003 ASCO Annual Meeting
Georgia Cancer Specialists (GCS) physicians Dr. Rodolfo Bordoni, Dr. Pradeep Jolly, Dr. Melvin Moore, and Dr. Mansoor Saleh traveled to Chicago recently to attend the American Society of Clinical Oncology (ASCO) Annual Meeting, held May 31 through June 3 at McCormick Place. Dr. Saleh presented two posters at the meeting and was listed as the co-author of five abstracts. In […]
Physicians, Employees, and Staff Honored at GCS Holiday Party
Georgia Cancer Specialists physicians, employees, and staff were honored for their commitment to excellence at the GCS Holiday Party, held December 13, 2003 at the Crowne Plaza Ravinia in Dunwoody, Georgia. “It was a terrific celebration of the season and our hard-working and talented group of physicians and employees,” said GCS CEO Dr. Bruce Feinberg. “These […]
Drs. Srinivasiah, Galleshaw, and Hawke Appear in Top Docs Issue of Atlanta Woman Magazine
Dr. Jayanthi Srinivasiah, Dr. Janice Galleshaw, and Dr. Wendy Hawke recently appeared in Atlanta Woman magazine about “Top Women Doctors” in the Atlanta area. Georgia Cancer Specialists’ Drs. Srinivasiah and Galleshaw accounted for two of only three women physicians singled out as “Top Docs” in the field of hematology/oncology in the March/April 2003 publication. GCS Chief Operations Officer, Dr. Wendy […]
New Colorectal Cancer Drug Succeeds in Clinical Trial
Georgia Cancer Specialists Was First in Georgia to Offer Patients Access to Trial A new cancer drug that works by blocking tumors’ access to oxygen and nutrients has been found to prolong the lives of patients with colorectal cancer. Doctors say the success of the drug, called Avastin, is providing insight into a new approach […]
Georgia Cancer Specialists Physicians Recognized as Leaders in Their Field
Drs. Bordoni and Galleshaw Often Chosen To Host Medical Events Georgia Cancer Specialists physicians Dr. Rodolfo Bordoni and Dr. Janice Galleshaw are often recognized as leaders in their field by being chosen to lead important medical events. “We are extremely proud of all our physicians at GCS,” said GCS CEO Dr. Bruce Feinberg. “The selections of Drs. Bordoni and Galleshaw […]
GCS Macon Office Stresses Cancer Prevention at the Cherry Blossom Health Fair
In a continued effort to serve the community’s health needs, the Georgia Cancer Specialists Macon office took part in the Cherry Blossom Health Fair on Saturday, March 22 at the Georgia Sports Hall of Fame in Macon, Georgia. The medical exposition, part of the International Cherry Blossom Festival, featured free health screenings, exhibits, and giveaways. […]
Dr. Carlos Franco Goes Live Before Millions Across Western Hemisphere on “CNN En Espanol”
If you watch the Spanish version of CNN, you may have seen Georgia Cancer Specialists physician Carlos Franco interviewed live about a recent genetics study that may help researchers understand how cancer cell growth is turned on and off. Dr. Carlos Franco, of the Alpharetta and Northside clinics, has been a frequent guest on CNN En Español, where […]
Rockdale Fiesta Celebrates 15 Years in the Community
In celebration of their 15 years in the community, the Georgia Cancer Specialists Rockdale office hosted a “Fiesta” on April 29 in Conyers, Georgia. The party, thrown in appreciation of all those in Rockdale who have supported GCS during the last 15 years, featured Mexican food and drinks, as well as a Mariachi band. “Rockdale […]
Clinical Trial Looks for Additional Use for Popular Breast Cancer Drug
The Breast Cancer International Research Group (BCIRG) is currently conducting a phase III clinical trial in hopes of discovering an additional effective use for the popular breast cancer drug Herceptin. BCIRG trial # 006 is, for the first time, testing the effectiveness of Herceptin in HER2 positive breast cancer patients in the adjuvant setting. The study is […]
